<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>854</number>
    <updateDate>2025-05-14T19:54:22Z</updateDate>
    <updateDateIncludingText>2025-05-14T19:54:22Z</updateDateIncludingText>
    <originChamber>Senate</originChamber>
    <originChamberCode>S</originChamberCode>
    <type>S</type>
    <introducedDate>2025-03-05</introducedDate>
    <congress>119</congress>
    <committees>
      <item>
        <systemCode>ssga00</systemCode>
        <name>Homeland Security and Governmental Affairs Committee</name>
        <chamber>Senate</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred To</name>
            <date>2025-03-05T16:53:32Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <relatedBills>
      <item>
        <title>Risky Research Review Act</title>
        <congress>119</congress>
        <number>1864</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2025-03-05</actionDate>
          <text>Referred to the Committee on Science, Space, and Technology, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2025-03-05</actionDate>
        <committees>
          <item>
            <systemCode>ssga00</systemCode>
            <name>Homeland Security and Governmental Affairs Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Homeland Security and Governmental Affairs.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2025-03-05</actionDate>
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <actionCode>10000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>P000603</bioguideId>
        <fullName>Sen. Paul, Rand [R-KY]</fullName>
        <firstName>Rand</firstName>
        <lastName>Paul</lastName>
        <party>R</party>
        <state>KY</state>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>P000595</bioguideId>
        <fullName>Sen. Peters, Gary C. [D-MI]</fullName>
        <firstName>Gary</firstName>
        <lastName>Peters</lastName>
        <party>D</party>
        <state>MI</state>
        <sponsorshipDate>2025-03-05</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects/>
      <policyArea>
        <name>Health</name>
        <updateDate>2025-03-10T18:19:33Z</updateDate>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2025-03-05</actionDate>
        <actionDesc>Introduced in Senate</actionDesc>
        <updateDate>2025-05-14T19:52:49Z</updateDate>
        <cdata>
          <text>&lt;p&gt;&lt;strong&gt;Risky Research Review Act&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;This bill establishes the Life Sciences Research Security Board to oversee the award of federal funding for high-risk life sciences research.&amp;nbsp;&lt;em&gt;High-risk life sciences research &lt;/em&gt;means&amp;nbsp;the study of an organism,&amp;nbsp;virus, or related product that could be misapplied to pose a significant threat to the public or could enhance the transmissibility or&amp;nbsp;virulence of certain high-risk&amp;nbsp;pathogens (e.g., Ebola).&lt;/p&gt;&lt;p&gt;Specifically, the bill establishes the board as an independent agency that must review proposed high-risk life sciences research, determine whether a federal agency may award funding for the research, and determine minimum required controls for funded research. Entities that are seeking federal funding must attest to whether their research is high-risk life sciences research. Agencies must certify the validity of these attestations and submit proposed high-risk life sciences research to the board. Agencies must also notify the board of intended awards for other life sciences research for potential review.&amp;nbsp;&lt;/p&gt;&lt;p&gt;In making&amp;nbsp;its determinations, the board must consider specified&amp;nbsp;factors,&amp;nbsp;including whether the benefits of the research outweigh the&amp;nbsp;risks. The bill prohibits agencies from awarding federal funding for high-risk life sciences research without approval of the board or for life sciences research currently under board review. The board may also&amp;nbsp;review awards that were made&amp;nbsp;before the billâ€™s enactment.&lt;/p&gt;&lt;p&gt;Entities that fail to properly&amp;nbsp;attest to the nature of their research may lose their eligibility for funding. Additionally, agency employees who fail to comply with the bill's requirements are subject to disciplinary action.&lt;/p&gt;</text>
        </cdata>
      </summary>
    </summaries>
    <title>Risky Research Review Act</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <titleTypeCode>45</titleTypeCode>
        <title>Risky Research Review Act</title>
        <updateDate>2025-03-07T16:38:24Z</updateDate>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <titleTypeCode>101</titleTypeCode>
        <title>Risky Research Review Act</title>
        <updateDate>2025-03-07T16:38:23Z</updateDate>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <titleTypeCode>6</titleTypeCode>
        <title>A bill to amend title 31, United States Code, to establish the Life Sciences Research Security Board, and for other purposes.</title>
        <updateDate>2025-03-07T16:33:24Z</updateDate>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in Senate</type>
        <date>2025-03-05T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-119s854is/xml/BILLS-119s854is.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2025-03-05</actionDate>
      <text>Read twice and referred to the Committee on Homeland Security and Governmental Affairs.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
